Kit for detecting relative expression index of leukemia BCR/ABL (m-bcr) fusion gene
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 南京艾迪康医学检验所有限公司
- Publication Date
- 2012-08-29
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of life science and biotechnology, in particular to a gene detection kit, which can detect human acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML) and a small number of chronic myeloid Detection of the expression level of BCR / ABL (m-bcr) fusion gene in patients with cellular leukemia (CML) can effectively save detection time and improve detection accuracy. Background technique
[0002] Leukemia is a kind of clonal malignant disease with abnormal hematopoietic stem cells. The leukemia cells in its clones lose the ability to further differentiate and mature and stagnate at different stages of cell development. In the bone marrow and other hematopoietic tissues, a large number of leukemia cells proliferate and accumulate and infiltrate other organs and tissues, and at the same time inhibit normal hematopoiesis. The clinical manifestations are anemia, bleeding, infection and infiltration of various organs....